Steward Partners Investment Advisory’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,500
Closed -$5K 2819
2020
Q1
$5K Hold
1,500
﹤0.01% 2117
2019
Q4
$7K Hold
1,500
﹤0.01% 2166
2019
Q3
$7K Hold
1,500
﹤0.01% 2176
2019
Q2
$9K Buy
+1,500
New +$7.23K ﹤0.01% 2050
2018
Q4
Sell
-1,500
Closed -$9K 2476
2018
Q3
$9K Hold
1,500
﹤0.01% 1941
2018
Q2
$12K Buy
+1,500
New +$11.4K ﹤0.01% 1685

Other funds holding PGNX

Steward Partners Investment Advisory's PGNX Position: Q2 2020 in Review

Steward Partners Investment Advisory sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 1,500 shares — an estimated $5K sold.

Steward Partners Investment Advisory first reported a position in PGNX in Q2 2018 and held it in 6 quarters. The position peaked at $12K in Q2 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Steward Partners Investment Advisory reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 1,500 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $5K.
  • Steward Partners Investment Advisory first reported a position in Progenics Pharmaceuticals Inc in Q2 2018 and held it in 6 quarters.
  • Steward Partners Investment Advisory's Progenics Pharmaceuticals Inc position peaked at $12K in Q2 2018.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2020, filed 6 Aug 2020.